Viewing Study NCT01147666

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-02-11 @ 10:52 AM
Study NCT ID: NCT01147666
Status: COMPLETED
Last Update Posted: 2022-01-11
First Post: 2010-05-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Roxadustat (FG-4592) in Participants With End-Stage Renal Disease Receiving Maintenance Hemodialysis
Sponsor: FibroGen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None End Stage Renal Disease View
None Anemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Kidney View
None End Stage Renal Disease View
None ESRD View
None Chronic Kidney Disease View
None CKD View
None Renal View
None Anemia View
None Oral anemia treatment View
None Hemoglobin levels View
None Blood count View
None Erythropoietin View
None Hemodialysis View
None Normoresponder View
None Hyporesponder View